BioengineeringbioRxivPreprint
Engineering nanoparticle surface chemistry for antigen-presenting cell targeting improves specificity and safety of TLR3 agonist cancer immunotherapy
Victoria F. Gomerdinger, Cassandra Parada, Andrea Li…·Paula Therese Hammond
This paper develops a nanoparticle platform to target TLR3 agonist to antigen-presenting cells, improving cancer immunotherapy safety and efficacy by reducing systemic toxicity and enhancing tumor targeting.
1 citation